Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 285

1.

Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy.

Trendowski MR, El-Charif O, Ratain MJ, Monahan P, Mu Z, Wheeler HE, Dinh PC Jr, Feldman DR, Ardeshir-Rouhani-Fard S, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Hannigan R, Strathmann F, Einhorn LH, Fossa SD, Travis LB, Dolan ME.

Clin Cancer Res. 2019 Jul 11. doi: 10.1158/1078-0432.CCR-19-0113. [Epub ahead of print]

PMID:
31296530
2.

Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.

Abu Zaid M, Dinh PC, Monahan PO, Fung C, El-Charif O, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Sesso HD, Huddart R, Mushiroda T, Kubo M, Dolan ME, Einhorn LH, Fossa SD, Travis LB; Platinum Study Group.

J Natl Compr Canc Netw. 2019 May 1;17(5):459-468. doi: 10.6004/jnccn.2018.7109.

PMID:
31085753
3.

Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms.

El Charif O, Mapes B, Trendowski MR, Wheeler HE, Wing C, Dinh PC Jr, Frisina RD, Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Gamazon ER, Cox NJ, Huddart R, Ardeshir-Rouhani-Fard S, Monahan P, Fossa SD, Einhorn LH, Travis LB, Dolan ME.

Clin Cancer Res. 2019 Jul 1;25(13):4104-4116. doi: 10.1158/1078-0432.CCR-18-3179. Epub 2019 Apr 5.

PMID:
30952644
4.

Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities.

Trendowski MR, El Charif O, Dinh PC Jr, Travis LB, Dolan ME.

Clin Cancer Res. 2019 Feb 15;25(4):1147-1155. doi: 10.1158/1078-0432.CCR-18-2244. Epub 2018 Oct 10. Review.

PMID:
30305294
5.

Risk of solid cancer after chemotherapy.

Fung C, Travis LB.

Nat Rev Urol. 2018 Nov;15(11):660-661. doi: 10.1038/s41585-018-0085-y. No abstract available.

PMID:
30177738
6.

Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors.

Fung C, Dinh P Jr, Ardeshir-Rouhani-Fard S, Schaffer K, Fossa SD, Travis LB.

Adv Urol. 2018 Feb 18;2018:8671832. doi: 10.1155/2018/8671832. eCollection 2018. Review.

7.

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, Sahasrabudhe DM, Cook R, Fossa SD, Einhorn LH, Travis LB; Platinum Study Group.

J Clin Oncol. 2018 May 20;36(15):1505-1512. doi: 10.1200/JCO.2017.77.0735. Epub 2018 Apr 4.

8.

Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score.

Feldman DR, Ardeshir-Rouhani-Fard S, Monahan P, Sesso HD, Fung C, Williams AM, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Zaid MA, Lipshultz SE, Einhorn LH, Oeffinger KC, Travis LB, Fossa SD; Platinum Study Group.

Clin Genitourin Cancer. 2018 Aug;16(4):e761-e769. doi: 10.1016/j.clgc.2018.01.011. Epub 2018 Feb 5.

9.

Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.

Zaid MA, Gathirua-Mwangi WG, Fung C, Monahan PO, El-Charif O, Williams AM, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse SK, Ardeshir-Rouhani-Fard S, Dinh PC, Sesso HD, Einhorn LH, Fossa SD, Travis LB; Platinum Study Group.

J Natl Compr Canc Netw. 2018 Mar;16(3):257-265. doi: 10.6004/jnccn.2017.7046.

10.

Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.

Dolan ME, El Charif O, Wheeler HE, Gamazon ER, Ardeshir-Rouhani-Fard S, Monahan P, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kim J, Fossa SD, Hertz DL, Mushiroda T, Kubo M, Einhorn LH, Cox NJ, Travis LB; Platinum Study Group.

Clin Cancer Res. 2017 Oct 1;23(19):5757-5768. doi: 10.1158/1078-0432.CCR-16-3224. Epub 2017 Jun 13.

11.

Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, Einhorn LH, Fossa SD, Travis LB; Platinum Study Group.

J Clin Oncol. 2017 Apr 10;35(11):1211-1222. doi: 10.1200/JCO.2016.70.3108. Epub 2017 Feb 27.

12.

Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.

Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF Jr, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Aleman BM, Travis LB, Morton LM, van Leeuwen FE.

Radiat Res. 2017 Feb;187(2):186-195. doi: 10.1667/RR14453.1. Epub 2017 Jan 24.

13.

Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.

Wheeler HE, Gamazon ER, Frisina RD, Perez-Cervantes C, El Charif O, Mapes B, Fossa SD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kollmannsberger C, Kim J, Mushiroda T, Kubo M, Ardeshir-Rouhani-Fard S, Einhorn LH, Cox NJ, Dolan ME, Travis LB.

Clin Cancer Res. 2017 Jul 1;23(13):3325-3333. doi: 10.1158/1078-0432.CCR-16-2809. Epub 2016 Dec 30.

14.

Increased pancreatic cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF Jr, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM, Fossa SD, Travis LB.

Br J Cancer. 2016 Sep 27;115(7):901-8. doi: 10.1038/bjc.2016.272. Epub 2016 Sep 6.

15.

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.

Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, Lipshultz SE, Dolan ME, Travis LB.

J Clin Oncol. 2016 Aug 10;34(23):2712-20. doi: 10.1200/JCO.2016.66.8822. Epub 2016 Jun 27.

16.

Reply to S. Alanee et al.

Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB.

J Clin Oncol. 2016 Apr 10;34(11):1285-6. doi: 10.1200/JCO.2015.65.7015. Epub 2016 Feb 8. No abstract available.

PMID:
26858338
17.

The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.

Kerns SL, Kundu S, Oh JH, Singhal SK, Janelsins M, Travis LB, Deasy JO, Janssens AC, Ostrer H, Parliament M, Usmani N, Rosenstein BS.

Semin Radiat Oncol. 2015 Oct;25(4):281-91. doi: 10.1016/j.semradonc.2015.05.006. Epub 2015 May 15. Review.

18.

Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.

Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB.

J Clin Oncol. 2015 Oct 1;33(28):3105-15. doi: 10.1200/JCO.2014.60.3654. Epub 2015 Aug 3.

19.

Long-term Morbidity of Testicular Cancer Treatment.

Fung C, Fossa SD, Williams A, Travis LB.

Urol Clin North Am. 2015 Aug;42(3):393-408. doi: 10.1016/j.ucl.2015.05.002. Epub 2015 Jun 10. Review.

PMID:
26216826
20.

c-MYC is a radiosensitive locus in human breast cells.

Wade MA, Sunter NJ, Fordham SE, Long A, Masic D, Russell LJ, Harrison CJ, Rand V, Elstob C, Bown N, Rowe D, Lowe C, Cuthbert G, Bennett S, Crosier S, Bacon CM, Onel K, Scott K, Scott D, Travis LB, May FE, Allan JM.

Oncogene. 2015 Sep 17;34(38):4985-94. doi: 10.1038/onc.2014.427. Epub 2014 Dec 22.

21.

Increased stomach cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Fossa SD, Stovall M, van Leeuwen FE, Johannesen TB, Rajaraman P, Gilbert ES, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Travis LB, Morton LM.

Br J Cancer. 2015 Jan 6;112(1):44-51. doi: 10.1038/bjc.2014.552. Epub 2014 Nov 4.

22.

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma.

Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Lamart S, Simon SL, Fraumeni JF Jr, Aleman BM, Curtis RE.

Haematologica. 2014 Oct;99(10):e193-6. doi: 10.3324/haematol.2014.108258. No abstract available.

23.

Pancreatic cancer risk after treatment of Hodgkin lymphoma.

Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF Jr, Aleman BM, Morton LM, Gilbert ES.

Ann Oncol. 2014 Oct;25(10):2073-9. doi: 10.1093/annonc/mdu287. Epub 2014 Jul 25.

24.

Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women.

Milano MT, Strawderman RL, Venigalla S, Ng K, Travis LB.

J Thorac Oncol. 2014 Aug;9(8):1081-90. doi: 10.1097/JTO.0000000000000213.

25.

Long-term cause-specific mortality in survivors of adolescent and young adult bone and soft tissue sarcoma: a population-based study of 28,844 patients.

Youn P, Milano MT, Constine LS, Travis LB.

Cancer. 2014 Aug 1;120(15):2334-42. doi: 10.1002/cncr.28733. Epub 2014 Apr 18.

26.

Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.

Travis LB, Fossa SD, Sesso HD, Frisina RD, Herrmann DN, Beard CJ, Feldman DR, Pagliaro LC, Miller RC, Vaughn DJ, Einhorn LH, Cox NJ, Dolan ME; Platinum Study Group.

J Natl Cancer Inst. 2014 Mar 12;106(5). pii: dju044. doi: 10.1093/jnci/dju044. Review.

27.

Reply to G. Gandaglia et al.

Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB.

J Clin Oncol. 2014 Apr 10;32(11):1167-9. doi: 10.1200/JCO.2013.54.6168. Epub 2014 Mar 3. No abstract available.

PMID:
24590643
28.

Age and Racial Differences among PSA-Detected (AJCC Stage T1cN0M0) Prostate Cancer in the U.S.: A Population-Based Study of 70,345 Men.

Zhang H, Messing EM, Travis LB, Hyrien O, Chen R, Milano MT, Chen Y.

Front Oncol. 2013 Dec 23;3:312. doi: 10.3389/fonc.2013.00312. eCollection 2013.

29.

Second malignant neoplasms and cardiovascular disease following radiotherapy.

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr.

Health Phys. 2014 Feb;106(2):229-46. doi: 10.1097/HP.0000000000000013. Review.

PMID:
24378498
30.

Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.

Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB.

J Clin Oncol. 2013 Oct 20;31(30):3807-14. doi: 10.1200/JCO.2013.50.3409. Epub 2013 Sep 16.

31.

Stomach cancer risk after treatment for hodgkin lymphoma.

Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB, Smith SA, Weathers RE, Andersson M, Fossa SD, Hauptmann M, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Pukkala E, Vaalavirta L, van den Belt-Dusebout AW, Fraumeni JF Jr, Travis LB, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2013 Sep 20;31(27):3369-77. doi: 10.1200/JCO.2013.50.6832. Epub 2013 Aug 26.

32.

Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer.

Kleinerman RA, Smith SA, Holowaty E, Hall P, Pukkala E, Vaalavirta L, Stovall M, Weathers R, Gilbert E, Aleman BM, Kaijser M, Andersson M, Storm H, Joensuu H, Lynch CF, Dores GM, Travis LB, Morton LM, Curtis RE.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):922-9. doi: 10.1016/j.ijrobp.2013.04.010. Epub 2013 May 22.

33.

Outcomes in stage I testicular seminoma: a population-based study of 9193 patients.

Beard CJ, Travis LB, Chen MH, Arvold ND, Nguyen PL, Martin NE, Kuban DA, Ng AK, Hoffman KE.

Cancer. 2013 Aug 1;119(15):2771-7. doi: 10.1002/cncr.28086. Epub 2013 Apr 30.

34.

Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.

Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK.

Nat Rev Clin Oncol. 2013 May;10(5):289-301. doi: 10.1038/nrclinonc.2013.41. Epub 2013 Mar 26. Review.

PMID:
23529000
35.

Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.

Elena JW, Travis LB, Simonds NI, Ambrosone CB, Ballard-Barbash R, Bhatia S, Cerhan JR, Hartge P, Heist RS, Kushi LH, Lash TL, Morton LM, Onel K, Pierce JP, Robison LL, Rowland JH, Schrag D, Sellers TA, Seminara D, Shu XO, Thomas NE, Ulrich CM, Freedman AN.

J Natl Cancer Inst. 2013 Jan 16;105(2):85-94. doi: 10.1093/jnci/djs473. Epub 2012 Nov 28. Review.

36.

Second malignant neoplasms: assessment and strategies for risk reduction.

Wood ME, Vogel V, Ng A, Foxhall L, Goodwin P, Travis LB.

J Clin Oncol. 2012 Oct 20;30(30):3734-45. doi: 10.1200/JCO.2012.41.8681. Epub 2012 Sep 24. Review.

PMID:
23008293
37.

Long-term survival among Hodgkin's lymphoma patients with gastrointestinal cancer: a population-based study.

Youn P, Li H, Milano MT, Stovall M, Constine LS, Travis LB.

Ann Oncol. 2013 Jan;24(1):202-8. doi: 10.1093/annonc/mds218. Epub 2012 Jul 31.

38.

Risk of treatment-related esophageal cancer among breast cancer survivors.

Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF Jr, Brown LM, van Leeuwen FE, Fossa SD, Johannesen TB, Langmark F, Lamart S, Travis LB, Aleman BM.

Ann Oncol. 2012 Dec;23(12):3081-91. doi: 10.1093/annonc/mds144. Epub 2012 Jun 27.

39.

Second malignant neoplasms in testicular cancer survivors.

Fung C, Fossa SD, Beard CJ, Travis LB.

J Natl Compr Canc Netw. 2012 Apr;10(4):545-56. Review.

PMID:
22491051
40.

Barriers to the implementation of surveillance for stage I testicular seminoma.

Arvold ND, Catalano PJ, Sweeney CJ, Hoffman KE, Nguyen PL, Balboni TA, Fosså SD, Travis LB, Beard CJ.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):383-9. doi: 10.1016/j.ijrobp.2011.11.064. Epub 2012 Feb 18.

PMID:
22349043
41.

Second malignant neoplasms and cardiovascular disease following radiotherapy.

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr.

J Natl Cancer Inst. 2012 Mar 7;104(5):357-70. doi: 10.1093/jnci/djr533. Epub 2012 Feb 6. Review.

42.

Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients.

Milano MT, Li H, Constine LS, Travis LB.

J Thorac Dis. 2012 Feb;4(1):22-9. doi: 10.3978/j.issn.2072-1439.2011.12.02.

43.

Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer.

Sprauten M, Darrah TH, Peterson DR, Campbell ME, Hannigan RE, Cvancarova M, Beard C, Haugnes HS, Fosså SD, Oldenburg J, Travis LB.

J Clin Oncol. 2012 Jan 20;30(3):300-7. doi: 10.1200/JCO.2011.37.4025. Epub 2011 Dec 19.

44.

Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patients.

Zhang H, Travis LB, Chen R, Hyrien O, Milano MT, Newlands SD, Chen Y.

Cancer. 2012 Mar 1;118(5):1276-87. doi: 10.1002/cncr.26357. Epub 2011 Jul 19.

45.

Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.

Milano MT, Li H, Constine LS, Travis LB.

Cancer. 2011 Dec 15;117(24):5538-47. doi: 10.1002/cncr.26257. Epub 2011 Jun 20.

46.

Long-term complications of lymphoma and its treatment.

Ng AK, LaCasce A, Travis LB.

J Clin Oncol. 2011 May 10;29(14):1885-92. doi: 10.1200/JCO.2010.32.8427. Epub 2011 Apr 11. Review.

PMID:
21483015
47.

Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients.

Fosså SD, Cvancarova M, Chen L, Allan AL, Oldenburg J, Peterson DR, Travis LB.

J Clin Oncol. 2011 Mar 10;29(8):963-70. doi: 10.1200/JCO.2010.32.3204. Epub 2011 Feb 7.

PMID:
21300926
48.

Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study.

Milano MT, Li H, Gail MH, Constine LS, Travis LB.

J Clin Oncol. 2010 Dec 1;28(34):5088-96. doi: 10.1200/JCO.2010.29.5683. Epub 2010 Oct 25.

49.

Testicular cancer survivorship: research strategies and recommendations.

Travis LB, Beard C, Allan JM, Dahl AA, Feldman DR, Oldenburg J, Daugaard G, Kelly JL, Dolan ME, Hannigan R, Constine LS, Oeffinger KC, Okunieff P, Armstrong G, Wiljer D, Miller RC, Gietema JA, van Leeuwen FE, Williams JP, Nichols CR, Einhorn LH, Fossa SD.

J Natl Cancer Inst. 2010 Aug 4;102(15):1114-30. doi: 10.1093/jnci/djq216. Epub 2010 Jun 28. Review.

50.

Evolving trends in insulin delivery in pursuit of improvements in diabetes management.

Akhrass F, Skinner N, Boswell K, Travis LB.

Am Health Drug Benefits. 2010 Mar;3(2):117-22.

Supplemental Content

Loading ...
Support Center